239 related articles for article (PubMed ID: 18927296)
1. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
[TBL] [Abstract][Full Text] [Related]
2. The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer.
Ford CE; Ekström EJ; Howlin J; Andersson T
Cell Cycle; 2009 Jun; 8(12):1838-42. PubMed ID: 19448401
[TBL] [Abstract][Full Text] [Related]
3. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells.
Ford CE; Ekström EJ; Andersson T
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3919-24. PubMed ID: 19237581
[TBL] [Abstract][Full Text] [Related]
4. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells.
Säfholm A; Leandersson K; Dejmek J; Nielsen CK; Villoutreix BO; Andersson T
J Biol Chem; 2006 Feb; 281(5):2740-9. PubMed ID: 16330545
[TBL] [Abstract][Full Text] [Related]
5. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
[TBL] [Abstract][Full Text] [Related]
6. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.
Hanaki H; Yamamoto H; Sakane H; Matsumoto S; Ohdan H; Sato A; Kikuchi A
Mol Cancer Ther; 2012 Feb; 11(2):298-307. PubMed ID: 22101459
[TBL] [Abstract][Full Text] [Related]
7. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.
Hansen C; Howlin J; Tengholm A; Dyachok O; Vogel WF; Nairn AC; Greengard P; Andersson T
J Biol Chem; 2009 Oct; 284(40):27533-43. PubMed ID: 19651774
[TBL] [Abstract][Full Text] [Related]
8. WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells.
Prasad CP; Chaurasiya SK; Axelsson L; Andersson T
Mol Oncol; 2013 Oct; 7(5):870-83. PubMed ID: 23727359
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
Shojima K; Sato A; Hanaki H; Tsujimoto I; Nakamura M; Hattori K; Sato Y; Dohi K; Hirata M; Yamamoto H; Kikuchi A
Sci Rep; 2015 Jan; 5():8042. PubMed ID: 25622531
[TBL] [Abstract][Full Text] [Related]
10. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
11. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines.
Pukrop T; Klemm F; Hagemann T; Gradl D; Schulz M; Siemes S; Trümper L; Binder C
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5454-9. PubMed ID: 16569699
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.
Canesin G; Evans-Axelsson S; Hellsten R; Krzyzanowska A; Prasad CP; Bjartell A; Andersson T
PLoS One; 2017; 12(9):e0184418. PubMed ID: 28886116
[TBL] [Abstract][Full Text] [Related]
14. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.
Jönsson M; Andersson T
J Cell Sci; 2001 Jun; 114(Pt 11):2043-53. PubMed ID: 11493640
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
[TBL] [Abstract][Full Text] [Related]
16. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.
Medrek C; Landberg G; Andersson T; Leandersson K
J Biol Chem; 2009 Apr; 284(16):10968-79. PubMed ID: 19244247
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
Manka D; Spicer Z; Millhorn DE
Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
[TBL] [Abstract][Full Text] [Related]
18. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
Jönsson M; Dejmek J; Bendahl PO; Andersson T
Cancer Res; 2002 Jan; 62(2):409-16. PubMed ID: 11809689
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.
Sand-Dejmek J; Ehrnström R; Berglund P; Andersson T; Ryden L
PLoS One; 2013; 8(8):e70890. PubMed ID: 23990917
[TBL] [Abstract][Full Text] [Related]
20. Wnt-5a regulates proliferation in lung cancer cells.
Huang Y; Liu G; Zhang B; Xu G; Xiong W; Yang H
Oncol Rep; 2010 Jan; 23(1):177-81. PubMed ID: 19956879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
